Incyte (INCY) Cash from Investing Activities (2010 - 2026)

Incyte (INCY) reported Cash from Investing Activities of -$88.2 million for Q1 2026, down 8140.38% on a YoY basis from $1.1 million in Q1 2025, and down 135.72% quarter-over-quarter from -$37.4 million in Q4 2025.

Incyte (INCY) Cash from Investing Activities (2010 - 2026) Analysis & Trends

Incyte has reported Cash from Investing Activities for 17 years, with the latest figure at -$88.2 million in Q1 2026.

  • For the quarter ending Q1 2026, Cash from Investing Activities fell 8140.38% year-over-year to -$88.2 million; the trailing twelve-month figure through Mar 2026 stood at -$191.9 million (down 182.82% YoY), and the FY2025 full-year result was -$102.6 million, down 165.14% from the prior year.
  • Cash from Investing Activities for Q1 2026 stood at -$88.2 million, down from -$37.4 million in the prior quarter.
  • The five-year high for Cash from Investing Activities was $213.8 million in Q2 2024, with the low at -$154.5 million in Q4 2023.
  • Historically, Cash from Investing Activities has averaged -$18.8 million across 5 years, with a median of -$20.9 million in 2022.
  • Annual changes were most pronounced in 2024 — Cash from Investing Activities surged 2978.18% — and 2026, when it tumbled 8140.38%.
  • Incyte's Cash from Investing Activities stood at -$20.9 million in 2022, then tumbled by 638.81% to -$154.5 million in 2023, then surged by 86.11% to -$21.5 million in 2024, then tumbled by 74.33% to -$37.4 million in 2025, then sank by 135.72% to -$88.2 million in 2026.
  • The last three Cash from Investing Activities figures came in at -$88.2 million (Q1 2026), -$37.4 million (Q4 2025), and -$47.4 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -2.89 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 638.50 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -431.90 Mn
9 Abivax 91.96 Bn 91.96 Bn - 579,519.10
10 Incyte 19.62 Bn 15.60 Bn 1.17 Bn -88.20 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -88.20 Mn
Mar 31, 2026 -88.20 Mn
Dec 31, 2025 -37.42 Mn
Dec 31, 2025 -37.42 Mn
Sep 30, 2025 -47.42 Mn
Sep 30, 2025 -47.42 Mn
Jun 30, 2025 -18.87 Mn
Jun 30, 2025 -18.87 Mn
Mar 31, 2025 1.10 Mn
Mar 31, 2025 1.10 Mn
Dec 31, 2024 -21.47 Mn
Dec 31, 2024 -21.47 Mn
Sep 30, 2024 38.27 Mn
Sep 30, 2024 38.27 Mn
Jun 30, 2024 213.82 Mn
Jun 30, 2024 213.82 Mn
Mar 31, 2024 -73.11 Mn
Mar 31, 2024 -73.11 Mn
Dec 31, 2023 -154.50 Mn
Dec 31, 2023 -154.50 Mn